High-dose penicillin G-treatment causes underestimation of serum albumin measured by a modified BCP method

Clinica Chimica Acta

Volumn 407, Issue 1-2, 2009, Pages 75-76

  Ono, Miyuki ^a   Aoki, Yoshimasa ^a   Masumoto, Michiko ^a   Hotta, Taeko ^a   Uchida, Yujiro ^a   Kayamori, Yuzo ^a   Kang, Dongchon ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BROMCRESOL PURPLE; PENICILLIN G;

ALBUMIN BLOOD LEVEL; BACTERIAL ENDOCARDITIS; CASE REPORT; CONTROLLED STUDY; CROSS REACTION; DRUG MEGADOSE; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; ARTIFACTS; BROMCRESOL PURPLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; HUMANS; PENICILLIN G; SERUM ALBUMIN;

EID: 67651172759     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.038     Document Type: Letter

References (12)

1. Peters T.J. All about albumin: biochemistry, genetics, and medical applications (1995), Academic Press, New York
2. Gustafsson J.E. Improved specificity of serum albumin determination and estimation of "acute phase reactants" by use of the bromcresol green reaction. Clin Chem 22 (1976) 616-622
3. Sogami M., Era S., Nagaoka S., Kuwata K., Kida K., Shigemi J., et al. High-performance liquid chromatographic studies on non-mercapt in equilibrium with mercapt conversion of human serum albumin. II. J Chromatogr 332 (1985) 19-27
4. Muramoto Y., Matsushita M., and Irino T. Reduction of reaction differences between human mercaptalbumin and human nonmercaptalbumin measured by the bromcresol purple method. Clin Chim Acta 289 (1999) 69-78
5. Sudlow G., Birkett D.J., and Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12 (1976) 1052-1061
6. Lafaye P., and Lapresle C. Location of penicilloyl groups on CNBr fragments of the albumin from penicillin-treated patients. FEBS Lett 220 (1987) 206-208
7. Lapresle C., and Lafaye P. Enzyme-linked immunosorbent assay for measurement of penicilloyl groups. Ann Inst Pasteur Immunol 136C (1985) 375-382
8. Yvon M., Anglade P., and Wal J.M. Binding of benzyl penicilloyl to human serum albumin. Evidence for a highly reactive region at the junction of domains 1 and 2 of the albumin molecule. FEBS Lett 247 (1989) 273-278
9. Yvon M., Anglade P., and Wal J.M. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Lett 263 (1990) 237-240
10. Yvon M., and Wal J.M. Identification of lysine residue 199 of human serum albumin as a binding site for benzylpenicilloyl groups. FEBS Lett 239 (1988) 237-240
11. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
12. Holland S.M., Livesey E.F., Owen J., Pennington G.W., Roberts J.B., and Somers G.F. Blood and urine levels following intramuscular administration of potassium penicillin V. Antibiot Chemother 10 (1960) 25-29